Loading patent…
AssigneesGenCell Corporation, The Regents of the University of California
InventorsPatrick Benoit, Bertrand Schwartz, Didier Branellec, Kenneth Chien, Ju Chen
Estimating the term…
The invention relates to novel promoter sequences derived from a portion upstream of the coding sequence of the gene for the CARP protein (Cardiac Ankyrin Repeat Protein), and which are capable of controlling the level and the specificity of expression of a transgene in vivo in cardiac muscle cells. The invention thus describes novel compositions, constructs, vectors and their uses in vivo for the transfer and expression of a nucleic acid in vivo in cardiac muscle cells. The subject of the present invention is also the use of the promoter sequences for generating transgenic animals which constitute models for studying certain cardiac pathologies.
1-39. (canceled)
A polynucleotide comprising a fragment of SEQ ID NO:
An expression cassette comprising a sequence encoding a protein or an RNA of therapeutic interest operably linked to the polynucleotide according to claim 4.
Dependencies are inferred from the claim text.